Literature DB >> 2604294

Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation.

A Wood1, T Higenbottam, M Jackson, J Scott, S Stewart, J Wallwork.   

Abstract

Bioelectrical potential difference (PD) across the respiratory mucosa is raised in cystic fibrosis (CF). We have recorded airway potentials from seven patients with CF who had undergone heart-lung transplantation and from eight patients without CF who had had transplants for cardiovascular disease; comparison of these populations controls for the effects of denervation and immunosuppressive treatment. Six patients without CF who had not had transplants formed an additional control. PD was recorded during routine fiberoptic bronchoscopy, using a Ringer's-perfused exploring bridge connected across a high impedance amplifier to an intravenous reference bridge. Bronchial lavage and sputum culture revealed no evidence of infection. Bronchial PD was similar in all three groups of patients at equivalent sites. However, nasal PD was raised in the CF group (mean value, 44 mV +/- 3.9 SE) compared with the patients who had transplants for cardiovascular disease (mean, 18 mV +/- 1.1 SE), and the control patients (mean, 15 mV +/- 1.2 SE). We conclude that the epithelial defects that result in raised airway potentials in CF do not recur in the transplanted lung.

Entities:  

Mesh:

Year:  1989        PMID: 2604294     DOI: 10.1164/ajrccm/140.6.1645

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Heart-lung transplantation for cystic fibrosis.

Authors:  T W Higenbottam; B Whitehead
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

Review 2.  Heart-lung transplantation for end-stage respiratory disease in cystic fibrosis patients.

Authors:  J P Scott; C Dennis; P Mullins
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

3.  Paediatric lung transplantation: the agony and the ecstasy.

Authors:  B F Whitehead; M R De Leval
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

4.  Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease.

Authors:  E Clini; L Bianchi; M Pagani; N Ambrosino
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

5.  Silver/silver chloride electrodes for measurement of potential difference in human bronchi.

Authors:  I Fajac; J Lacronique; A Lockhart; J Dall'Ava-Santucci; D J Dusser
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

6.  Cystic fibrosis. 5. The current state of lung transplantation for cystic fibrosis.

Authors:  R L Smyth; T Higenbottam; J Scott; J Wallwork
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

7.  Heart-lung transplantation for cystic fibrosis. 2: Outcome.

Authors:  B Whitehead; P Helms; M Goodwin; I Martin; J P Scott; R L Smyth; T W Higenbottam; J Wallwork; M Elliott; M de Leval
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

8.  In vitro bioelectric properties of bronchial epithelium from transplanted lungs in recipients with cystic fibrosis.

Authors:  V T Tsang; E W Alton; M E Hodson; M Yacoub
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

9.  Heart-lung transplantation for cystic fibrosis.

Authors:  M E Hodson
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.